Clinical Trial Update: Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta [Phase 4]

View source ↗

Summary

A Phase 4 study completed to assess if restarting interferon-beta therapy after a washout period is beneficial for relapsing-remitting multiple sclerosis patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED